Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies

The HIPK2 (serine/threonine homeodomain-interacting protein kinase 2) is a “caretaker” gene, its inactivation increases tumorigenicity while its activation inhibits tumor growth. This report reviews the anti-tumorigenic mechanisms of HIPK2, which include promotion of apoptosis, inhibition of angioge...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yuanyuan, Zhou, Lihong, Sun, Xiaoting, Li, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386776/
https://www.ncbi.nlm.nih.gov/pubmed/28107201
http://dx.doi.org/10.18632/oncotarget.14723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386776/
https://www.ncbi.nlm.nih.gov/pubmed/28107201
http://dx.doi.org/10.18632/oncotarget.14723

Ejemplares similares